+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dried Blood Spot Collection Cards Market - Global Forecast to 2030- Product Image
Dried Blood Spot Collection Cards Market - Global Forecast to 2030- Product Image
Sale

Dried Blood Spot Collection Cards Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337148
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dried Blood Spot Collection Cards Market grew from USD 384.31 million in 2024 to USD 406.04 million in 2025. It is expected to continue growing at a CAGR of 5.60%, reaching USD 533.13 million by 2030.

Over the past decade, dried blood spot collection cards have transformed the way clinicians, researchers, and diagnostic laboratories approach sample collection. By enabling minimally invasive sampling, these cards reduce patient discomfort and logistical complexity, especially in remote or resource-limited settings. The stability of analytes at ambient temperatures minimizes cold-chain dependencies, streamlining transportation and storage. As telemedicine and decentralized healthcare models gain momentum, demand for reliable, easy-to-use collection tools has surged. Concurrently, technological advances in card substrates-from traditional cellulose matrices to glass fiber and polymer-based formats-have broadened analytical sensitivity and expanded the range of detectable biomarkers. This executive summary provides a concise yet comprehensive examination of the core market forces, regulatory developments, and competitive strategies that will shape the dried blood spot collection card landscape in the coming years.

Transformative Shifts Reshaping the Dried Blood Spot Card Landscape

The dried blood spot collection card market is undergoing a paradigm shift driven by five major forces. First, digital integration through blockchain and QR-code traceability is enhancing sample provenance and data integrity, enabling stakeholders to track individual cards from collection to analysis. Second, supply chain resilience has become paramount: manufacturers are securing diversified raw-material sources and forging regional production hubs to mitigate geopolitical risk. Third, regulatory frameworks in key markets are converging on unified standards for extractable volume, analyte recovery, and quality control, accelerating global market access for compliant suppliers. Fourth, patient-centric models-spanning home self-collection kits and decentralized clinical trials-are unlocking new growth opportunities by decentralizing diagnostic workflows. Finally, sustainability mandates are prompting innovation in biodegradable and recyclable substrates, allowing industry leaders to meet environmental targets without sacrificing performance. Taken together, these transformative shifts are rebalancing competitive dynamics, triggering strategic alliances and product portfolios that align with evolving end-user needs and regulatory expectations.

Assessing the Cumulative Impact of U.S. Tariffs in 2025

In 2025, newly enacted U.S. tariffs targeting imported raw materials and finished lab supplies are exerting upward pressure on production costs for dried blood spot collection cards. Cellulose substrates sourced from overseas suppliers face duty increments of up to 15%, while specialized glass fiber membranes and polymer films are subject to a 10% levy. These tariff measures have led many manufacturers to reevaluate supply chains, with nearshoring initiatives aimed at reducing exposure to import duties. As cost bases rise, suppliers are exploring value-engineering strategies-reducing card thickness, optimizing punching techniques, and integrating multi-spot layouts-to preserve price competitiveness. Meanwhile, diagnostic centers and research laboratories are confronting higher per-sample costs, prompting procurement teams to renegotiate long-term contracts and consider alternative platforms. Regulatory bodies are responding by clarifying duty classifications for advanced substrates, offering temporary relief for novel bio-compatible polymers. In aggregate, the 2025 tariff environment is accelerating both supply-chain diversification and product innovation, underscoring the need for agile strategic planning.

Key Segmentation Insights Driving Market Dynamics

Segmentation analysis reveals distinct dynamics across product, end-user, application, and collection mode categories. When dissected by product type, cellulose remains the benchmark for affordability and widespread adoption, glass fiber cards excel in high-sensitivity assays, and emerging polymer options offer improved chemical inertness. Within this product classification, format variations such as flat and folded cards provide flexibility in shipping and storage, while population targeting spans both animal and human sampling. Quantity per card differentiation between multi-spot and single-spot formats optimizes throughput for large-scale screening versus specialized analyses. From the end-user perspective, diagnostic centers-comprising general diagnostic facilities and specialized diagnostic centers-drive consistent demand, whereas home care settings leverage home visit services and self-testing kits to support chronic-care models. Hospitals and clinics, split between private clinics and public hospitals, prioritize streamlined workflows, and pharmaceutical companies engaged in drug development and drug discovery increasingly rely on dried blood spot sampling for preclinical and clinical studies. Research laboratories, whether focused on academic research, clinical trials, or corporate R&D, are embracing these cards for their operational efficiency. Application-based segmentation highlights disease monitoring across chronic illnesses, lifestyle diseases, and pandemic surveillance, while doping and drug testing covers recreational use and sports doping. Forensic testing addresses crime scene investigation and paternity tests, infectious disease screening spans bacterial, parasitic, and viral disease detection, newborn screening targets genetic, hormonal, and metabolic disorders, and therapeutic drug monitoring includes antibiotics, antiepileptics, and immunosuppressants. Finally, sample collection modes-capillary, finger prick, heel prick, and venous blood collection-offer tailored approaches suited to patient populations and logistical constraints.

Key Regional Insights and Growth Opportunities

Regional analysis uncovers differentiated growth drivers and challenges across major territories. In the Americas, established neonatal screening programs, a robust clinical trial ecosystem, and rapid adoption of point-of-care diagnostics sustain strong market expansion. Meanwhile, Europe, Middle East & Africa are benefiting from regulatory harmonization efforts that streamline cross-border approvals, coupled with rising public-private partnerships to enhance rural healthcare outreach. In Asia-Pacific, surging investments in healthcare infrastructure, a growing middle-class patient base, and escalating chronic disease prevalence are fueling demand for decentralized sampling solutions. Local manufacturing initiatives in Asia-Pacific are also reducing lead times and fostering competitive pricing, while in the Americas and EMEA, ongoing efforts to reinforce supply-chain resilience are creating opportunities for regional distribution hubs. Collectively, these factors underscore the importance of tailored go-to-market strategies that align with each region’s regulatory, economic, and healthcare priorities.

Leading Companies Shaping the Dried Blood Spot Card Market

Competitive landscapes are defined by established players and innovative challengers alike. Ahlstrom Oyj and ARCHIMEDlife GmbH lead in cellulose-based substrate production, leveraging high-yield manufacturing processes and global distribution networks. Bioanalytical Systems, Inc. by Inotiv and BioDynamics LLC specialize in analytical validation services and custom card formats for research applications, while BioIVT LLC by PrecisionMed, LLC focuses on integrated sample collection and bioanalysis offerings. Cambrian Bioworks LLP and Capitainer AB are advancing polymer-based materials and volumetric sampling technologies, respectively, and Centogene N.V. integrates genomic data analytics with dried blood spot workflows. Eastern Business Forms, Inc. and F. Hoffmann-La Roche Ltd. maintain high-volume production capacity, and Innovatek Medical Inc. together with Merck KGaA expand into advanced preservative and stabilization chemistries. Monobind Inc. and Novilytic LLC deliver turnkey self-collection kits, while PanoHealth, LLC and PerkinElmer, Inc. drive automation and lab-information-management integrations. Shimadzu Corporation and Thermo Fisher Scientific Inc. provide complementary analytical instrumentation, and Trajan Scientific and Medical offers niche solutions for forensic and specialized clinical testing. This competitive plurality underscores the need for strategic partnerships and continuous technological advancement.

Actionable Recommendations for Industry Leaders

Industry leaders should adopt a multifaceted approach to capitalize on emerging opportunities. First, invest in R&D to refine substrate chemistries and optimize spot uniformity, ensuring superior analyte recovery across diverse assays. Second, diversify supply chains by establishing regional production or forging dual-sourcing agreements to mitigate tariff exposure and logistical disruptions. Third, deepen regulatory engagement by participating in standards-setting bodies and pursuing early conformity certifications in key markets. Fourth, expand decentralized sampling offerings through partnerships with home-health and telemedicine providers, leveraging self-collection kits and virtual training platforms. Fifth, integrate digital tracking and blockchain-enabled provenance systems to enhance sample security and regulatory compliance. Sixth, pursue cross-sector collaborations with diagnostic instrument manufacturers and contract research organizations, unlocking bundled solutions for end users. Finally, embed sustainability principles by developing recyclable substrates and minimizing packaging waste, aligning with corporate social responsibility goals and customer expectations.

Conclusion and Strategic Outlook

The dried blood spot collection card market stands at the intersection of technological innovation, regulatory evolution, and shifting healthcare delivery models. As tariffs reshape cost structures and regional markets mature at varying rates, success will hinge on agility and strategic foresight. Organizations that invest in advanced materials, embrace decentralized sampling paradigms, and cultivate resilient supply chains will outpace competitors. Moreover, alignment with emerging regulatory standards and environmental sustainability targets will serve as key differentiators. Ultimately, the companies that marry product innovation with integrated digital solutions and patient-centric delivery will capture sustained growth and deliver measurable value to healthcare stakeholders worldwide.

Market Segmentation & Coverage

This research report categorizes the Dried Blood Spot Collection Cards Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Card Type
    • Cellulose
    • Glass Fiber
    • Polymer
  • Format
    • Flat Cards
    • Folded Cards
  • Population Type
    • Animal
    • Human
  • Quantity Per Card
    • Multi-Spot Cards
    • Single Spot Cards
  • Diagnostic Centers
    • General Diagnostic Facilities
    • Specialized Diagnostic Centers
  • Home Care Settings
    • Home Visit Services
    • Self-Testing Kits
  • Hospitals and Clinics
    • Private Clinics
    • Public Hospitals
  • Pharmaceutical Companies
    • Drug Development
    • Drug Discovery
  • Research Laboratories
    • Academic Research
    • Clinical Trials
    • Corporate Research
  • Disease Monitoring
    • Chronic Illnesses
    • Lifestyle Diseases
    • Pandemic Monitoring
  • Doping and Drug Testing
    • Recreational Drug Use
    • Sports Doping
  • Forensic Testing
    • Crime Scene Investigation
    • Paternity Tests
  • Infectious Diseases Screening
    • Bacterial Diseases
    • Parasitic Diseases
    • Viral Diseases
  • Newborn Screening
    • Genetic Disorders
    • Hormonal Disorders
    • Metabolic Disorders
  • Therapeutic Drug Monitoring
    • Antibiotics
    • Antiepileptics
    • Immunosuppressants
  • Capillary Collection
  • Finger Prick Collection
  • Heel Prick Collection
  • Venous Blood Collection

This research report categorizes the Dried Blood Spot Collection Cards Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Dried Blood Spot Collection Cards Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Ahlstrom Oyj
  • ARCHIMEDlife GmbH
  • Bioanalytical Systems, Inc. by Inotiv, Inc.
  • BioDynamics LLC
  • BioIVT LLC by PrecisionMed, LLC
  • Cambrian Bioworks LLP
  • Capitainer AB
  • Centogene N.V.
  • Eastern Business Forms, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Innovatek Medical Inc.
  • Merck KGaA
  • Monobind Inc.
  • Novilytic LLC
  • PanoHealth, LLC
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Trajan Scientific and Medical

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dried Blood Spot Collection Cards Market, by Product Type
8.1. Introduction
8.2. Card Type
8.2.1. Cellulose
8.2.2. Glass Fiber
8.2.3. Polymer
8.3. Format
8.3.1. Flat Cards
8.3.2. Folded Cards
8.4. Population Type
8.4.1. Animal
8.4.2. Human
8.5. Quantity Per Card
8.5.1. Multi-Spot Cards
8.5.2. Single Spot Cards
9. Dried Blood Spot Collection Cards Market, by End User
9.1. Introduction
9.2. Diagnostic Centers
9.2.1. General Diagnostic Facilities
9.2.2. Specialized Diagnostic Centers
9.3. Home Care Settings
9.3.1. Home Visit Services
9.3.2. Self-Testing Kits
9.4. Hospitals and Clinics
9.4.1. Private Clinics
9.4.2. Public Hospitals
9.5. Pharmaceutical Companies
9.5.1. Drug Development
9.5.2. Drug Discovery
9.6. Research Laboratories
9.6.1. Academic Research
9.6.2. Clinical Trials
9.6.3. Corporate Research
10. Dried Blood Spot Collection Cards Market, by Application
10.1. Introduction
10.2. Disease Monitoring
10.2.1. Chronic Illnesses
10.2.2. Lifestyle Diseases
10.2.3. Pandemic Monitoring
10.3. Doping and Drug Testing
10.3.1. Recreational Drug Use
10.3.2. Sports Doping
10.4. Forensic Testing
10.4.1. Crime Scene Investigation
10.4.2. Paternity Tests
10.5. Infectious Diseases Screening
10.5.1. Bacterial Diseases
10.5.2. Parasitic Diseases
10.5.3. Viral Diseases
10.6. Newborn Screening
10.6.1. Genetic Disorders
10.6.2. Hormonal Disorders
10.6.3. Metabolic Disorders
10.7. Therapeutic Drug Monitoring
10.7.1. Antibiotics
10.7.2. Antiepileptics
10.7.3. Immunosuppressants
11. Dried Blood Spot Collection Cards Market, by Sample Collection Mode
11.1. Introduction
11.2. Capillary Collection
11.3. Finger Prick Collection
11.4. Heel Prick Collection
11.5. Venous Blood Collection
12. Americas Dried Blood Spot Collection Cards Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Dried Blood Spot Collection Cards Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Dried Blood Spot Collection Cards Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ahlstrom Oyj
15.3.2. ARCHIMEDlife GmbH
15.3.3. Bioanalytical Systems, Inc. by Inotiv, Inc.
15.3.4. BioDynamics LLC
15.3.5. BioIVT LLC by PrecisionMed, LLC
15.3.6. Cambrian Bioworks LLP
15.3.7. Capitainer AB
15.3.8. Centogene N.V.
15.3.9. Eastern Business Forms, Inc.
15.3.10. F. Hoffmann-La Roche Ltd.
15.3.11. Innovatek Medical Inc.
15.3.12. Merck KGaA
15.3.13. Monobind Inc.
15.3.14. Novilytic LLC
15.3.15. PanoHealth, LLC
15.3.16. PerkinElmer, Inc.
15.3.17. Shimadzu Corporation
15.3.18. Thermo Fisher Scientific Inc.
15.3.19. Trajan Scientific and Medical
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DRIED BLOOD SPOT COLLECTION CARDS MARKET MULTI-CURRENCY
FIGURE 2. DRIED BLOOD SPOT COLLECTION CARDS MARKET MULTI-LANGUAGE
FIGURE 3. DRIED BLOOD SPOT COLLECTION CARDS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DRIED BLOOD SPOT COLLECTION CARDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DRIED BLOOD SPOT COLLECTION CARDS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRIED BLOOD SPOT COLLECTION CARDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY GLASS FIBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FLAT CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FOLDED CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY MULTI-SPOT CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SINGLE SPOT CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY GENERAL DIAGNOSTIC FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SPECIALIZED DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME VISIT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SELF-TESTING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CORPORATE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CHRONIC ILLNESSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY LIFESTYLE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PANDEMIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RECREATIONAL DRUG USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SPORTS DOPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CRIME SCENE INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PATERNITY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ANTIEPILEPTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CAPILLARY COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FINGER PRICK COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HEEL PRICK COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY VENOUS BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 138. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 140. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 141. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 142. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 143. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 145. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 146. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 147. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 148. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 149. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 151. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 152. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 153. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 154. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 155. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 156. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 157. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 160. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 162. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 167. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 168. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 170. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 171. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 172. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 173. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 174. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 175. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 235. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 237. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 238. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 239. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 240. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 242. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 243. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 244. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 245. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 246. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 248. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 249. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 250. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 251. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 252. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 253. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 254. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 256. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 257. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 258. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 259. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 261. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 262. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 263. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 264. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 265. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 267. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 268. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 269. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INFECTIOUS DISEASES SCREENING, 2018-2030 (USD MILLION)
TABLE 270. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 271. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 272. INDIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE COLLECTION MODE, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CARD TYPE, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POPULATION TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY QUANTITY PER CARD, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE MONITORING, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DOPING AND DRUG TESTING, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TESTING, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE,

Companies Mentioned

  • Ahlstrom Oyj
  • ARCHIMEDlife GmbH
  • Bioanalytical Systems, Inc. by Inotiv, Inc.
  • BioDynamics LLC
  • BioIVT LLC by PrecisionMed, LLC
  • Cambrian Bioworks LLP
  • Capitainer AB
  • Centogene N.V.
  • Eastern Business Forms, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Innovatek Medical Inc.
  • Merck KGaA
  • Monobind Inc.
  • Novilytic LLC
  • PanoHealth, LLC
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Trajan Scientific and Medical

Methodology

Loading
LOADING...

Related Topics

Related Reports

Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Dried Blood Spot Collection Cards - Global Strategic Business Report - Product Image

Dried Blood Spot Collection Cards - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
2025 Global Forecast for Dried Blood Spot Collection Cards Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Dried Blood Spot Collection Cards Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Dried Blood Spots. Applications and Techniques. Edition No. 1. Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods - Product Image

Dried Blood Spots. Applications and Techniques. Edition No. 1. Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods

  • Book
  • 376 Pages
Automatic Blood Coagulation Analysis Pipeline Market - Global Forecast to 2030 - Product Image

Automatic Blood Coagulation Analysis Pipeline Market - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From

About the Dried Blood Spot Market

The Dried Blood Spot (DBS) market is a subset of the coagulation and hemostasis testing market. DBS is a method of collecting and testing blood samples that involves collecting a small amount of blood on a filter paper card. This method is used to test for a variety of conditions, including hemophilia, thrombophilia, and other bleeding disorders. DBS is a cost-effective and convenient alternative to traditional venipuncture, as it requires less blood and can be collected in a variety of settings. The DBS market is expected to grow due to the increasing prevalence of bleeding disorders, the growing demand for point-of-care testing, and the increasing adoption of DBS technology. Additionally, the development of new technologies and the increasing availability of DBS kits are expected to drive the market growth. Some of the major companies in the DBS market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Grifols. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.